#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease Hypertriglyceridaemia Dementia Alzheimer's type Meningococcal immunisation Follicle centre lymphoma follicular grade I, II – III Bulbospinal muscular atrophy congenital Ureteric cancer Uveal melanoma Amyotrophic lateral sclerosis Metastases to peritoneum Congenital myopathy Neuroblastoma recurrent Hereditary angioedema with C1 esterase inhibitor deficiency Gestational trophoblastic tumour Infertility female More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Treatment Antisynthetase syndrome – Treatment Mast cell activation syndrome – Diagnostics Breast angiosarcoma – Diagnostics Mantle cell lymphoma stage III – Diagnostics CADASIL – Life with Disease Lysosomal storage disorder – Treatment Skin angiosarcoma – Diagnostics Nephrotic syndrome Shprintzen-Goldberg syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRIMIPRAMINE MALEATE Panitumumab Glepaglutide Alnus Glutinosa Pollen Fosinopril Sodium Mitomycin Fluocinolone Acetonide Epirubicin Testosterone Undecanoate Efavirenz Nirmatrelvir Mva-209-Fsp-B1 Metamizole Magnesium Regadenoson Elenestinib Phosphate Streptococcus Pneumoniae Meclofenamate Sodium Ambrosia Artemisiifolia (302) Sacubitril Valsartan Lbl-007 More therapies…

    Learn about Your Condition

    Cutaneous T-cell lymphoma Corneal graft failure Becker's muscular dystrophy Lyme disease Lung neoplasm malignant Gastrectomy Psychotic disorder Alveolar bone defect Endocarditis Pulmonary tuberculosis Hodgkin's disease refractory K-ras gene mutation Bipolar disorder Mixed-type liposarcoma Mechanical ventilation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine for Preventing Pneumonia in Adults Aged 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Spain
  • Study on the Safety and Efficacy of Tretinoin with Radiation Therapy for Patients with Oligometastatic Solid Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Tretinoin
    France
  • Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Volrustomig
    • Infliximab
    • Mycophenolate Mofetil
    Denmark Germany Italy Norway Poland Spain
  • Study on Baclofen for Reducing Benzodiazepine Use in Patients with Benzodiazepine Dependence

    Recruiting

    4 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Azelastine Hydrochloride
    • Baclofen
    • Zopiclone
    France
  • Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Lumateperone
    Bulgaria France Lithuania Spain
  • Study on Preventing Cardiovascular Collapse in Critically Ill Adults Using Noradrenaline Tartrate During Tracheal Intubation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Noradrenaline Tartrate
    Ireland Italy
Previous Page
1 … 444 445 446 447 448 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!